Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence

Table 3 Utility input data [29–33]

Health state	Disutility value	Utility value (HIV-); baseline value = 1	Utility value (HIV+); baseline value = 0.81
No HPV	0	1	0.81
HPV-Onc	0	1	0.81
CIN1	0	1	0.81
CIN1 det	0.013	0.987	0.797
CIN2/3	0	1	0.81
CIN2/3 det	0.013	0.987	0.797
Cervical cancer	0.273	0.727	0.537
Cervical cancer cured	0.062	0.938	0.748

CIN, cervical intraepithelial neoplasia; CIN1, CIN grade 1; CIN2/3, CIN grade 2 or 3; det, detected; HIV, human immunodeficiency virus; HIV-, HIV-negative; HIV+, HIV + positive; HPV, human papillomavirus

ISSN: 1471-2334